Anlotinib as a promising inhibitor on tumor growth of oral squamous cell carcinoma through cell apoptosis and mitotic catastrophe

Overview of attention for article published in Cancer Cell International, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 17 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

METTL3 suppresses anlotinib sensitivity by regulating m6A modification of FGFR3 in oral squamous cell carcinoma

Cancer Cell International, 27 Sep 2022

Abstract Background N6-methyladenosine (m6A) is an abundant nucleotide modification in mRNA, but there were few studies on its…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.